Tumor Ablation Companies | Market Research Future

Top Industry Leaders in the Tumor Ablation Market

*Disclaimer: List of key companies in no particular orderLatest Tumor ablation Companies Update

February 2023: NovaSure V5 global endometrial ablation (GEA) device has been approved in Canada and Europe, according to Hologic Inc., a world leader in women's health. This updated and improved version is equipped to deal with a variety of cervical and uterine structures. It adds to NovaSure's stellar success rate; the gadget has already helped 3 million people. Increased sealing surface and adaptability to a variety of cervical canals and anatomical variability are the goals of the new cervical seal in NovaSure V5, which makes use of EndoFormTM technology.1,2,3 AccuSheathTM marks are intended to inspire trust and assurance in the user during sitting and fundal placement. Increased sealing surface and adaptability to a variety of cervical canals and anatomical variability are the goals of the new cervical seal in NovaSure V5, which makes use of EndoFormTM technology.

April 2023: Leading Taiwanese electronics manufacturer Compal Electronics has declared a new focus on creating cutting-edge therapeutic medical gadgets. A new Bilevel ventilator for COPD and respiratory insufficiency due to central and/or mixed apneas, and a new radiofrequency ablation (RFA) system for percutaneous, intraoperative coagulation and ablation of soft tissue, including partial or complete ablation of non-resectable liver lesions, have both been released by Compal. To reduce the size of the wound and the length of time patients spend in the hospital, the "AblatePal" RF ablation system makes use of the heat energy produced by electrical resistance when the current passes through the tissue to cauterize the tumor, causing tumor necrosis.

List of Tumor ablation Key companies in the market